Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
31m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
31m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
31m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
31m agoFirst Quantum Minerals Reports First Quarter 2026 Results
31m agoDistrict Metals Announces $10 Million Private Placement Financing
Climb Bio Inc logo

Climb Bio Inc

About

Climb Bio Inc (NASDAQ:CLYM) — investor relations, events, news, and company updates on 6ix.

Latest News

Yesterday
Climb Bio, Inc. Announces $110.0 Million Private Placement
Apr 8 2026
Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026
Apr 7 2026
Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy
Mar 5 2026
Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Mar 5 2026
Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates 

Financials

Revenue
$0
Market Cap
$459.56 M
EPS
-0.88

Community Chat

Ask AI

6ix6ixAIEvents